Modification of the tryptophanyl residue and its effects on the immunological and biological activity of human chorionic somatomammotropin

Tryptophan residue is essential for immunoreactivity of a diagnostically relevant peptide epitope of A. fumigatus

The role of tryptophan (Trp17) in immunoreactivity of P1, the diagnostically relevant peptide from a major allergen/antigen of Aspergillus fumigatus, was evaluated by chemically modifying tryptophanyl residue of P1. In BIAcore kinetic studies, unmodified P1 showed a 100-fold higher binding with ABPA (Allergic Bronchopulmonary Aspergillosis) patients' IgG [KD (equilibrium dissociation constant) = 2.74 e(-8) +/- 0.13 M] than the controls' IgG (KD = 2.97 e(-6) +/- 0.14 M), whereas chemically-modified P1 showed similar binding [KD patients' IgG = 3.25 e(-7) +/- 0.16 M, KD controls' IgG = 3.86 e(-7) +/- 0.19 M] indicating loss of specific immunoreactivity of P1 on tryptophan modification. Modified P1 showed loss of specific binding to IgE and IgG antibodies of ABPA patients in ELISA (Enzyme-Linked Immunosorbent Assay). The study infers that tryptophan residue (Trp17) is essential for immunoreactivity of P1.

Activity of alkylated prolactin and human growth hormone in receptor and cell assays

The disulfide bonds of two lactogenic hormones, ovine prolactin (oPRL) and human growth hormone (hGH), were reduced with dithiothreitol under denaturing conditions and alkylated with iodoacetic acid. The modified hormones were assayed for their ability to bind the plasma membrane-bound receptor for lactogenic hormone found in the rabbit mammary gland. S-Carboxymethylated ovine prolactin (SCM-oPRL) with all six cysteine residues modified had a nearly 300-fold decrease in binding as compared to native oPRL in a competitive binding assay using [125I]ovine prolactin. The S-carboxymethylated human growth hormone (SCM-hGH) had all four of its cysteine residues modified. It showed only a slightly reduced ability to bind the rabbit mammary gland prolactin receptor in a competitive binding assay with [125I]ovine prolactin. The two modified hormones were assayed for their ability to stimulate proliferation of the lactogen-dependent Nb 2 lymphoma cell line. SCM-oPRL required concentrations greater than 1 X 10(5) that of native oPRL to stimulate 50% of the maximum cell growth. SCM-hGH retained a significant amount of its ability to stimulate the Nb 2 lymphoma cells.